In particular, the methylation levels of MAPT in the blood of AD patients have not been investigated, therefore the expression levels and the methylation status of MAPT in blood of AD patients and age‐ and sex‐matched healthy controls were investigated. The gene discussed is MAPT; the disease is Alzheimer disease.